Company news
Sansure Biotech Inc. news in 2025
Sansure Biotech Inc.'s news releases, calls and decks from 2025, newest first.
Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan
December 19, 2025
Announcement on Voluntary Disclosure in the Related Product Obtaining the EU CE Certification
December 11, 2025
Indicative Announcement on Proposed Judicial Freezing and Enforcement of Some Shares Held by Shareholder with Over 5% Shares
December 5, 2025
Announcement on Resolutions of the 5th Extraordinary Meeting of the 3rd Board of Directors in 2025
November 28, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 25, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
November 17, 2025
Announcement on Voluntary Disclosure in the Related Product Obtaining the Medical Device Registration Certificate and the EU CE Certification
November 7, 2025
Announcement on Resignation of Core Technical Personnel
October 30, 2025
Announcement on Establishing a Fund through Co-investment with Professional Institutions and Related Party Transaction
October 21, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 16, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
September 15, 2025
Full Text of 2025 Semi-annual Report
August 29, 2025
Announcement on Attending the Interim Collective Performance Briefing of Listed Companies in Hunan Province on SSE STAR Market 2025
August 26, 2025
Announcement on Completion of Board of Directors Re-election and Appointment of Senior Management Member & Securities Affairs Representative
August 5, 2025
Self-Inspection Report on the Trading of Company's Stock by Information Insiders in 2025 Restricted Stock Incentive Plan
July 29, 2025
Inspection Opinions and Publicity Description of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects for the 2025 Restricted Stock Incentive Plan
July 24, 2025
Announcement on Term Change and Election of Board of Directors
July 11, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Product
June 23, 2025
Announcement on Accepting Partial Equity of Hunan Shengwei Sirui Biotechnology Co., Ltd. and Joint Investment with Related Parties
June 12, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 4, 2025
Announcement on the Phased Progress in Acquiring Equity of Zhongshan Sansure Hygene Biomedicine Co., Ltd.
May 23, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 16, 2025
Announcement on Capital Increase of Hunan Shengwei Kunteng Biotechnology Co., Ltd. and Joint Investment with Related Parties
May 8, 2025
Full Text of 2024 Annual Report
April 28, 2025